Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. A. F. Simoes, J. R. Groothuis, X. Carbonell-Estrany, I. Mitchell, L. M. Fredrick, J. L. Kimpen (Denver, San Diego, Abbott Park, United States Of America; Barcelona, Spain; Bochum, Germany; Utrecht, Netherlands). Palivizumab prophylaxis, respiratory syncytial virus and subsequent recurrent wheezing: a 2-year follow-up study. Eur Respir J 2006; 28: Suppl. 50, 4368

Member's Comments

No comment yet.

Related content which might interest you: Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Respiratory syncytial virus infection in childhood: a follow-up of children hospitalised for wheezing in infancy Source: Eur Respir J 2003; 22: Suppl. 45, 141s Year: 2003 Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Prevalence of respiratory syncytial virus (RSV) hospitalisation, and subsequent airway symptoms in late preterm infants Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008 Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004 In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study Source: Eur Respir J, 59 (3) 2100651; 10.1183/13993003.00651-2021 Year: 2022 The role of respiratory syncytial virus and rhinovirus in early recurrent wheeze and asthma inception – a systematic review Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up Source: Eur Respir J 2012; 39: 396-402 Year: 2012 Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity Source: Annual Congress 2006 - Virus-induced respiratory tract infection Year: 2006 Are infants with respiratory syncytial virus (RSV) bronchiolitis different from infants with non RSV bronchiolitis for the development of wheezing in the first year of life? Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005 Bronchiolitis in infants and children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=170 Year: 2006 Interleukin 13 genetic polymorphism identifies children with late wheezing following respiratory syncytial virus infection Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007 Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants Source: Eur Respir J 2014; 44: 666-674 Year: 2014 Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020 Prophylaxis against respiratory syncytial virus in high-risk infants Source: Eur Respir Monogr 2021; 92: 361-371 Year: 2021 Monozygotic twins discordant for severe respiratory syncytial virus infection in infancy: clinical long-term follow-up of asthma prevalence, lung function and sensitization Source: Eur Respir J 2007; 30: Suppl. 51, 711s Year: 2007 Incidence of respiratory syncytial virus (RSV) positivity in young Italian children referred to the emergency departments for lower respiratory tract infection (LRTI) over two consecutive epidemic seasons Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004 Efficacy and safety of palivizumab in preterm infants 29-32 weeks gestational age without chronic lung disease to prevent serious respiratory syncytial virus respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 531s Year: 2002 Epidemiology of severe respiratory syncytial virus infection in Ethiopian infants : A prospective study Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020